{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:01:02Z","timestamp":1761940862813,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.tox.2006.02.019","type":"journal-article","created":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T07:13:31Z","timestamp":1143875611000},"page":"240-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats"],"prefix":"10.1016","volume":"222","author":[{"given":"Tadashi","family":"Itoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Moto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitoshi","family":"Mitsumori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2006.02.019_bib1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/AAC.42.5.1284","article-title":"Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases","volume":"42","author":"Akasaka","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2006.02.019_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/mutage\/10.4.343","article-title":"Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems","volume":"10","author":"Albertini","year":"1995","journal-title":"Mutagenesis"},{"key":"10.1016\/j.tox.2006.02.019_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2165\/00002018-199207030-00006","article-title":"Mutagenicity of quinolone antibacterials","volume":"7","author":"Fort","year":"1992","journal-title":"Drug Safety"},{"key":"10.1016\/j.tox.2006.02.019_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1349-7006.1996.tb03114.x","article-title":"A topoisomerase II inhibitor, NK109, induces DNA single- and double-strand breaks and apoptosis","volume":"87","author":"Fukuda","year":"1996","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.tox.2006.02.019_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.13.3.479","article-title":"Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids","volume":"13","author":"Greenwood","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2006.02.019_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1383-5718(01)00275-3","article-title":"Ciprofloxacin: in vivo genotoxicity studies","volume":"498","author":"Herbold","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2006.02.019_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mrgentox.2005.11.003","article-title":"Genotoxic potential of quinolone antimicrobials in the in vitro comet assay and micronucleus test","volume":"603","author":"Itoh","year":"2006","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2006.02.019_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/toxsci\/69.2.317","article-title":"Mechanistic study on flumequine hepatocarcinogenicity focusing on DNA damage in mice","volume":"69","author":"Kashida","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2006.02.019_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1073\/pnas.96.3.881","article-title":"Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tox.2006.02.019_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/mutage\/3.5.397","article-title":"Evaluation of the DNA-damaging and mutagenic activity of oxolinic and pipemidic acids by the granuloma pouch assay","volume":"3","author":"Maura","year":"1988","journal-title":"Mutagenesis"},{"key":"10.1016\/j.tox.2006.02.019_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/01480549109017868","article-title":"Toxicity and carcinogenicity studies of nalidixic acid in rodents","volume":"14","author":"Morrissey","year":"1991","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tox.2006.02.019_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-7992(93)90029-U","article-title":"Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo","volume":"301","author":"Mukherjee","year":"1993","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2006.02.019_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1293\/tox.15.95","article-title":"The effects of allyl alcohol-induced cell proliferation for detection of initiation activities of chemicals in rat liver","volume":"15","author":"Okamura","year":"2002","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2006.02.019_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-7992(91)90049-A","article-title":"Evaluation of DNA damage induced by norfloxacin in liver and kidney of adult rats and in fetal tissues after transplacental exposure","volume":"264","author":"Pino","year":"1991","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2006.02.019_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0304-3835(99)00306-7","article-title":"Summation of initiation activities of low doses of the non-hepatocarcinogen 1,2-dimethylhydrazine in the liver after carbon tetrachloride administration","volume":"148","author":"Sakai","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tox.2006.02.019_bib16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1349-7006.2001.tb01055.x","article-title":"Differential effects of partial hepatectomy and carbon tetrachloride administration on induction of liver cell foci in a model for detection of initiation activity","volume":"92","author":"Sakai","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.tox.2006.02.019_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(01)00727-3","article-title":"Summation of initiation activities in the liver after partial hepatectomy","volume":"176","author":"Sakai","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tox.2006.02.019_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3835(02)00009-5","article-title":"Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity","volume":"188","author":"Sakai","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tox.2006.02.019_bib19","first-page":"378","article-title":"Mutagenicity of the new quinolone antibacterial agent levofloxacin","volume":"43","author":"Shimada","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tox.2006.02.019_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1383-5718(02)00284-X","article-title":"Genotoxicity of lomefloxacin\u2014an antibacterial drug in somatic and germ cells of Swiss albino mice in vivo","volume":"535","author":"Singh","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2006.02.019_bib21","first-page":"1157","article-title":"Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens","volume":"40","author":"Tsuda","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2006.02.019_bib22","unstructured":"WHO, 1998. Evaluation of certain veterinary drug residues in food. Forty-eighth report of the Joint FAO\/WHO Expert Committee on Food Additives. World Health Organ Technical Report Series. 879, i\u2013vi, 1\u201373."},{"key":"10.1016\/j.tox.2006.02.019_bib23","unstructured":"WHO, 2003. Evaluation of certain veterinary drug residues in food. World Health Organ Technical Report Series. 918, i\u2013vi, 1\u201359, back cover."},{"key":"10.1016\/j.tox.2006.02.019_bib24","unstructured":"WHO, 2004. Evaluation of certain veterinary drug residues in food. Sixty-second report of the Joint FAO\/WHO Expert Committee on food additives. World Health Organ Technical Report Series. 925, 1\u201372."},{"key":"10.1016\/j.tox.2006.02.019_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0278-6915(94)90037-X","article-title":"Carcinogenicity studies of oxolinic acid in rats and mice","volume":"32","author":"Yamada","year":"1994","journal-title":"Food Chem. Toxicol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X0600134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X0600134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:55:04Z","timestamp":1759532104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X0600134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0300483X0600134X"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2006.02.019","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2006.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}